Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

6,018 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Adjuvant chemotherapy of S-1 versus gemcitabine for resected pancreatic cancer: a phase 3, open-label, randomised, non-inferiority trial (JASPAC 01).
Uesaka K, Boku N, Fukutomi A, Okamura Y, Konishi M, Matsumoto I, Kaneoka Y, Shimizu Y, Nakamori S, Sakamoto H, Morinaga S, Kainuma O, Imai K, Sata N, Hishinuma S, Ojima H, Yamaguchi R, Hirano S, Sudo T, Ohashi Y; JASPAC 01 Study Group. Uesaka K, et al. Among authors: shimizu y. Lancet. 2016 Jul 16;388(10041):248-57. doi: 10.1016/S0140-6736(16)30583-9. Epub 2016 Jun 2. Lancet. 2016. PMID: 27265347 Clinical Trial.
Efficacy of peroral pancreatoscopy in the diagnosis of pancreatic diseases.
Yamao K, Ohashi K, Nakamura T, Suzuki T, Sawaki A, Hara K, Fukutomi A, Baba T, Okubo K, Tanaka K, Moriyama I, Fukuda K, Matsumoto K, Shimizu Y. Yamao K, et al. Among authors: shimizu y. Gastrointest Endosc. 2003 Feb;57(2):205-9. doi: 10.1067/mge.2003.72. Gastrointest Endosc. 2003. PMID: 12556785
Acute portal vein thrombosis after EUS-guided FNA of pancreatic cancer: case report.
Matsumoto K, Yamao K, Ohashi K, Watanabe Y, Sawaki A, Nakamura T, Matsuura A, Suzuki T, Fukutomi A, Baba T, Okubo K, Tanaka K, Moriyama I, Shimizu Y. Matsumoto K, et al. Among authors: shimizu y. Gastrointest Endosc. 2003 Feb;57(2):269-71. doi: 10.1067/mge.2003.79. Gastrointest Endosc. 2003. PMID: 12556803 No abstract available.
Pancreaticobiliary maljunction in monozygotic twins--a case report.
Yamao K, Shimizu Y, Ohashi K, Matsuura A, Nakamura T, Suzuki T, Watanabe Y, Sawaki A, Takeda K, Hara K, Fukutomi A, Matsumoto K. Yamao K, et al. Among authors: shimizu y. Hepatogastroenterology. 2004 May-Jun;51(57):675-8. Hepatogastroenterology. 2004. PMID: 15143891 Review.
Clinical outcome of elderly patients with unresectable pancreatic cancer treated with gemcitabine plus S-1, S-1 alone, or gemcitabine alone: Subgroup analysis of a randomised phase III trial, GEST study.
Imaoka H, Kou T, Tanaka M, Egawa S, Mizuno N, Hijioka S, Hara K, Yazumi S, Shimizu Y, Yamao K. Imaoka H, et al. Among authors: shimizu y. Eur J Cancer. 2016 Feb;54:96-103. doi: 10.1016/j.ejca.2015.11.002. Epub 2015 Dec 30. Eur J Cancer. 2016. PMID: 26741729 Clinical Trial.
Clinicopathological Characteristics of Young Patients With Pancreatic Cancer: An Analysis of Data From Pancreatic Cancer Registry of Japan Pancreas Society.
Eguchi H, Yamaue H, Unno M, Mizuma M, Hamada S, Igarashi H, Kuroki T, Satoi S, Shimizu Y, Tani M, Tanno S, Hirooka Y, Fujii T, Masamune A, Mizumoto K, Itoi T, Egawa S, Kodama Y, Tanaka M, Shimosegawa T; Committee of Clinical Research, Japan Pancreas Society. Eguchi H, et al. Among authors: shimizu y. Pancreas. 2016 Nov;45(10):1411-1417. doi: 10.1097/MPA.0000000000000636. Pancreas. 2016. PMID: 27171511
Multicenter study of early pancreatic cancer in Japan.
Kanno A, Masamune A, Hanada K, Maguchi H, Shimizu Y, Ueki T, Hasebe O, Ohtsuka T, Nakamura M, Takenaka M, Kitano M, Kikuyama M, Gabata T, Yoshida K, Sasaki T, Serikawa M, Furukawa T, Yanagisawa A, Shimosegawa T; Japan Study Group on the Early Detection of Pancreatic Cancer (JEDPAC). Kanno A, et al. Among authors: shimizu y. Pancreatology. 2018 Jan;18(1):61-67. doi: 10.1016/j.pan.2017.11.007. Epub 2017 Nov 20. Pancreatology. 2018. PMID: 29170051
Health-related quality of life of adjuvant chemotherapy with S-1 versus gemcitabine for resected pancreatic cancer: Results from a randomised phase III trial (JASPAC 01).
Hagiwara Y, Ohashi Y, Uesaka K, Boku N, Fukutomi A, Okamura Y, Konishi M, Matsumoto I, Kaneoka Y, Shimizu Y, Nakamori S, Sakamoto H, Morinaga S, Kainuma O, Imai K, Sata N, Hishinuma S, Ojima H, Yamaguchi R, Hirano S, Sudo T; JASPAC 01 Study Group. Hagiwara Y, et al. Among authors: shimizu y. Eur J Cancer. 2018 Apr;93:79-88. doi: 10.1016/j.ejca.2018.01.081. Epub 2018 Mar 20. Eur J Cancer. 2018. PMID: 29477795 Clinical Trial.
6,018 results